Trial intelligence / Profile preview

INOLIN (trimetoquinol) urinary detectability study in healthy adults

jRCT1080224102Completed

Sponsor
LSI Medience Corporation
Start
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of Tretoquinol, sponsored by LSI Medience Corporation. Primary endpoints: Detectable period of unchanged trimetoquinol in urine and Detectable period of trimetoquinol metabolites in urine. Started Oct 2018; status: completed.

02

Drugs

Tretoquinol

Beyond the preview

Go deeper on jRCT1080224102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080224102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call